1. Global Tuberculosis Report (2023) https://www.who.int/publications-detail-redirect/9789240083851 (Accessed on 6th November, 2023)
2. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment. https://www.who.int/publications/i/item/9789240048126 (Accessed on 6th November, 2023)
3. Frieden T (2004) What is intermittent treatment and what is the scientific basis for intermittency? In: Frieden T (ed) Toman’s tuberculosis: case detection, treatment, and monitoring—questions and answers, 2nd edn. World Health Organization, Geneva, Switzerland, pp 130–138. Publication No. WHO/HTM/TB/2004.334
4. Feleke BE, Alene GD, Feleke TE, Motebaynore Y, Biadglegne F (2018) Clinical response of tuberculosis patients, a prospective cohort study. PLoS ONE 13(1):e0190207. https://doi.org/10.1371/journal.pone.0190207
5. Heysell SK, Moore JL, Keller SJ, Houpt ER (2010) Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA. Emerg Infect Dis 16(10):1546–1553. https://doi.org/10.3201/eid1610.100374